BioCentury
ARTICLE | Company News

GeneCentric Diagnostics, University of North Carolina deal

September 3, 2012 7:00 AM UTC

The university granted molecular diagnostic company GeneCentric exclusive, worldwide rights to commercialize Hypoxia Signature and exclusive rights to Lung Subtype Platform technology. Hypoxia Signatu...